Inventor · disambiguated record
Hossein A. Ghanbari
Also filed as: GHANBARI HOSSEIN · GHANBARI HOSSEIN A
18 granted patents·38 pending applications·269 citations·filing 1987–2023
93Inventor score
Files withPANACEA PHARMACEUTICALS INC13ATHANOR BIOSCIENCES INC4GHANBARI HOSSEIN A4NYMOX CORP4PANACEA PHARMACEUTICALS4
Top patents by PatentIndex Score
56 records- 0195US6942858B1Compositions containing bacteriophages and methods of using bacteriophages to treat infectionsNYMOX CORP·Filed 2000·Granted Sep 13, 2005·50 cites·12 claims
- 0292US6835370B2Diagnosis and treatment of malignant neoplasmsRHODE ISLAND HOSPITAL·Filed 2001·Granted Dec 28, 2004·34 cites·10 claims
- 0391US6121036ACompositions containing bacteriophages and methods of using bacteriophages to treat infectionsFiled 1997·Granted Sep 19, 2000·94 cites·15 claims
- 0480US5811310AThe Alz-50 monoclonal antibody and diagnostic assay for alzheimer's diseaseEINSTEIN COLL MED·Filed 1994·Granted Sep 22, 1998·47 cites·5 claims
- 0579US9744223B2Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2013·Granted Aug 29, 2017·4 cites·9 claims
- 0673US7521479B2Methods of treating prion disease in mammalsPANACEA PHARMACEUTICALS INC·Filed 2001·Granted Apr 21, 2009·3 cites·14 claims
- 0767US7456179B2Methods of treating ischemic related conditionsPANACEA PHARMACEUTICALS INC·Filed 2004·Granted Nov 25, 2008·6 cites·1 claims
- 0867US2010172832A1Diagnosis and treatment of malignant neoplasmsRHODE ISLAND HOSPITAL·Filed 2009·Application pending·0 cites
- 0964US2005113329A1Diagnosis and treatment of malignant neoplasmsRHODE ISLAND HOSPITAL·Filed 2004·Application pending·0 cites
- 1063US10702591B2Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylasePANACEA PHARMACEUTICALS INC·Filed 2017·Granted Jul 7, 2020·0 cites·6 claims
- 1160US2009155289A1Furin-cleavable peptide linkers for drug-ligand conjugatesROBERTS STEVE·Filed 2008·Application pending·0 cites
- 1259US2014356930A1Immune system enhancing immunotherapy for the treatment of cancerPANACEA PHARMACEUTICALS·Filed 2013·Application pending·0 cites
- 1358US6518314B1Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptionsNYMOX CORP·Filed 2000·Granted Feb 11, 2003·1 cites·9 claims
- 1458US2020246443A1Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1557US2023346862A1Cancer eradicating - bio-nanoparticles (ce-bnp)ATHANOR BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1656US2018036424A1Immune system enhancing immunotherapy for the treatment of cancerPANACEA PHARMACEUTICALS·Filed 2017·Application pending·0 cites
- 1756US2021148915A9Recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human sera from cancer patientsPANACEA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1855US10525044B2Treatment for chemotherapy-induced peripheral neuropathyPANACEA PHARMACUETICAL INC·Filed 2017·Granted Jan 7, 2020·0 cites·12 claims
- 1954US5429947ADiagnosing Alzheimer's disease and schizophreniaFiled 1992·Granted Jul 4, 1995·18 cites·5 claims
- 2054US2005260171A1Compositions containing bacteriophages and method of using bacteriophages to treat infectionsNYMOX CORP·Filed 2005·Application pending·0 cites
- 2154US2010093002A1Diagnosis and treatment of malignant neoplasmsWANDS JACK R·Filed 2007·Application pending·0 cites
- 2253US2005123545A1Diagnosis and treatment of malignant neoplasmsFiled 2004·Application pending·0 cites
- 2353US2023050559A1Size-based detection and quantification of functional bio-nanoparticlesATHANOR BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2453US2008124718A1Methods of diagnosing, predicting therapeutic efficacy and screening for new therapeutic agents for leukemiaPANACEA PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2552US2017072034A1Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2651US6130221APharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptionsNYMOX CORP·Filed 1997·Granted Oct 10, 2000·4 cites·9 claims
- 2751US2004146945A1Olfactory neuron cultures and method of making and using the samePANACEA PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2851US2011124016A1Diagnosis and Treatment of Malignant NeoplasmsWANDS JACK R·Filed 2010·Application pending·0 cites
- 2951US2004146946A1Olfactory neuron cultures and method of making and using the samePANACEA PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 3050US2016077098A1Recovery of aspartyl (asparaginyl) beta hydroxylase (haah) from an exosomal fraction of human sera from cancer patientsSEMENUK MARK·Filed 2015·Application pending·0 cites
- 3149US11826421B2Bacteriophage-based vaccines and engineered bacteriophageATHANOR BIOSCIENCES INC·Filed 2021·Granted Nov 28, 2023·0 cites·21 claims
- 3249US2008039471A1Composition and method to inhibit tissue plasminogen activator (tPA) - potentiated neurotoxicityGHANBARI HOSSEIN A·Filed 2006·Application pending·0 cites
- 3348US2021309973A1Bacteriophage-Based Antibodies and BindersATHANOR BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3448US2002197258A1Compositions and methods for preventing protein aggregation in neurodegenerative diseasesFiled 2002·Application pending·0 cites
- 3548US2014271689A1Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-beta-Hydroxylase)BISWAS BISWAJIT·Filed 2013·Application pending·0 cites
- 3647US2009298097A1Methods for the diagnosis of lung cancerHARRIS PAMELA J·Filed 2008·Application pending·0 cites
- 3747US2007179147A1Methods of treating and preventing Alzheimer's diseaseJIANG ZHI-GANG·Filed 2006·Application pending·0 cites
- 3846US11369717B2Fibrous nerve conduit for promoting nerve regenerationGHANBARI HOSSEIN·Filed 2020·Granted Jun 28, 2022·0 cites·8 claims
- 3946US2002016284A1Olfactory neuron cultures and method of making and using the sameFiled 2001·Application pending·0 cites
- 4046US2009275587A1Methods of treating ischemic related conditionsALMASSIAN BIJAN·Filed 2008·Application pending·0 cites
- 4145US2020345820A1Combination therapies for cancerSENSEI BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4245US2014363489A1Treatment of eye diseasePANACEA PHARMACEUTICALS·Filed 2013·Application pending·0 cites
- 4344US10166303B2Radio-imaging and radio-therapy of cancer using antibodies to HAAHPANACEA PHARMACEUTICALS INC·Filed 2016·Granted Jan 1, 2019·0 cites·12 claims
- 4444US2020390902A1Antibody-Drug Conjugates Targeted at Human Aspartyl-(Asparaginyl)-B-Hydroxylase (HAAH)PANACEA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4543US10576069B2Treatment for chemotherapy-induced cognitive impairmentPANACEA PHARMACEUTICAL INC·Filed 2016·Granted Mar 3, 2020·0 cites·21 claims
- 4642US2019049455A1HAAH and MMP-9 are Complementary Cancer Biomarkers and Predictors of Metastasis when CombinedPANACEA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4740US2019345261A1Aspartate beta-hydroxylase chimeric antigen receptors and uses thereofSENSEI BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4840US2015110853A1Treatment of radical prostatectomy-induced erectile dysfunctionGHANBARI HOSSEIN A·Filed 2013·Application pending·0 cites
- 4939US2020121773A1Compositions and methods for manufacturing bacteriophage cancer vaccines and uses thereofSENSEI BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 5039US2002177614A1Methods for treating nuerodegenerative diseases including alzheimer'sFiled 2001·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hossein A. Ghanbari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →